Scarica l'app Stockscreener
6.76
1.60%
-0.11
Pre-mercato:
6.81
0.05
+0.74%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Astria Therapeutics Inc Borsa (ATXS) Ultime notizie
JMP Securities Increases Astria Therapeutics (NASDAQ:ATXS) Price Target to $26.00 - Defense World
Why Astria Therapeutics Inc. stock attracts strong analyst attention2025 Stock Rankings & Real-Time Chart Breakout Alerts - Newser
Can trapped investors hope for a rebound in Astria Therapeutics Inc.Gap Down & Free Long-Term Investment Growth Plans - Newser
Price action breakdown for Astria Therapeutics Inc.Inflation Watch & Low Drawdown Investment Ideas - Newser
Astria Therapeutics Reports Increased Losses Amid R&D Expansion - TipRanks
Signal strength of Astria Therapeutics Inc. stock in tech scannersVolume Spike & Pattern Based Trade Signal System - Newser
Astria Therapeutics price target raised to $26 from $25 at Citizens JMP - MSN
Can Astria Therapeutics Inc. Regain Lost Ground This QuarterWeekly Trend Summary & Accurate Entry and Exit Point Alerts - metal.it
Long term hold vs stop loss in Astria Therapeutics Inc.Earnings Recap Summary & Daily Entry Point Alerts - Newser
Astria Therapeutics stock price target raised to $26 by JMP on HAE program progress - Investing.com Canada
Shining A Light On Astria Therapeutics As Its Atopic Dermatitis Drug Approaches A Key Milestone - RTTNews
Technical signs of recovery in Astria Therapeutics Inc.July 2025 Review & Entry Point Confirmation Alerts - Newser
Astria Therapeutics Inc. stock momentum explainedMarket Activity Summary & Technical Pattern Based Buy Signals - Newser
Can Astria Therapeutics Inc. hit a new high this monthWeekly Profit Report & AI Based Buy and Sell Signals - Newser
Applying sector rotation models to Astria Therapeutics Inc.Analyst Downgrade & Safe Capital Growth Plans - Newser
How high can Astria Therapeutics Inc. stock goRisk Aware Trading Ideas with Alert Levels - Newser
Astria Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update - BioSpace
Astria Therapeutics Inc. stock prediction for this weekRisk Adjusted Trade Signal Screening Tool - Newser
what makes astria therapeutics inc. stock price move sharplyFree Sector Rotation Based Trading Opportunities - Newser
Astria Therapeutics, Inc. SEC 10-Q Report - TradingView
Is it time to cut losses on Astria Therapeutics Inc.Pre-Market Stock Movement Summary and Review - Newser
What earnings revisions data tells us about Astria Therapeutics Inc.Weekly Chart Watchlist with Trade Guidance - Newser
How to build a dashboard for Astria Therapeutics Inc. stockWeekly Market Direction and Sector Summary - Newser
Will Astria Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsFree Market Momentum and Signal Alerts - Newser
How Astria Therapeutics Inc. stock performs during market volatilityFree Momentum Based Equity Trading Plan - Newser
Is Astria Therapeutics Inc. showing signs of accumulationInvestment Roadmap for High Potential Stocks - Newser
Astria Therapeutics (ATXS) Projected to Post Earnings on Monday - Defense World
Astria licenses rare disease drug Navenibart to Japan’s Kaken Pharma in $32 M deal - BioSpectrum Asia
Astria Therapeutics shares fall 1.15% intraday after being dropped from multiple Russell indices. - AInvest
Astria Therapeutics licenses navenibart rights to Kaken for HAE - Pharmaceutical Technology
How to escape a deep drawdown in Astria Therapeutics Inc.Chart Confirmation Setup with ROI Signals - Newser
0.11%
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):